|All Children's Hospital And Moffitt Cancer Center Join Forces Against Cancer|
All Children's Hospital And Moffitt Cancer Center Join Forces Against Cancer
(October 12, 2004) St. Petersburg, FL – In an agreement that combines the strengths of Florida’s two preeminent cancer programs, Tampa’s H. Lee Moffitt Cancer Center & Research Institute today signed an affiliation agreement with All Children’s Hospital in St. Petersburg.
"We are very proud of our pediatric cancer program here at All Children's, and pleased to be partnering with Moffitt to work toward new understanding of cancer, and better treatments," said Gary Carnes, President and CEO, All Children's Health System. Our philosophy of family-centered care and our commitment to treatment, education and research nicely compliment Moffitt's goals as an NCI-recognized Comprehensive Cancer Center. Ultimately, the long-term goal of both organizations is to end cancer in children and adults. This new relationship is a demonstrable step to reach that goal.”
Moffitt CEO and Center Director William S. Dalton, Ph.D., M.D., says the affiliation "will allow us to combine efforts on research and treatment options. We will be better able to share resources and information in such areas as genetics, General Clinical Research Centers, novel therapies and other areas of mutual interest." Referring to the Department of Defense-funded Bill and Beverly Young National Functional Genomics Center at Moffitt, he explains, "We have begun to analyze the molecular profile of tumors to ultimately determine what treatment works best for each individual. This affiliation will further expand those benefits to children with cancer.”
“This is a continued fulfillment of our original vision and mission,” Moffitt Executive Vice President and CFO Jack Kolosky adds. “We were created by the Legislature for this purpose – to be a resource for the entire state of Florida in cancer care, research and education. We believe that two of Florida’s preeminent specialty organizations can combine efforts for the greater good.”
Physicians and staff at both institutions also gain tremendous benefit from this partnership, as they will have access to a variety of academic conferences and interdisciplinary educational programs designed to strengthen and expand cancer programs for adults and children.
In 2001 the National Cancer Institute awarded Moffitt the status of a Comprehensive Cancer Center - in recognition of its excellence in research and contributions to clinical trials, prevention and cancer control. Additionally, Moffitt is a member of the National Comprehensive Cancer Network, a prestigious alliance of the country's leading cancer centers, and is listed in the U.S. News & World Report as one of the Top 10 cancer hospitals in America. Moffitt's sole mission is to contribute to the prevention and cure of cancer.
As part of its legislative mandate, the Moffitt Cancer Center is seeking to improve the quality of cancer care for all Florida residents by establishing an affiliate network of hospitals and physicians throughout the state to disseminate new innovations in cancer treatments and research into the community. All Children’s was chosen to be an affiliate of Moffitt because of its high quality Pediatric Hematology/Oncology program.
All Children’s Hospital has consistently ranked among the nation’s top 20 children’s hospitals, as surveyed by Child Magazine. In 2004, the American Society of Clinical Oncology recognized the pediatric cancer program at All Children’s Hospital as one of ten recipients nationwide for its Clinical Trials Participation Award. All Children’s was the only pediatric program in the nation to receive the award, honoring programs for the role they play in furthering the search for cancer cures through participation in clinical research trials.
All Children’s Pediatric Hematology/Oncology Program under the direction of founder Jerry Barbosa, M.D., has grown over its 25-year history to become one of the largest children’s cancer programs in the Southeastern United States. Fully 70-80% of the children treated in Dr. Barbosa’s program participate in cooperative studies that track patients’ progress through standardized treatment protocols and share that data among children’s oncology programs nationwide.
“This is particularly important in making any advances in the treatment of children with cancer,” explains Dr. Barbosa. “Compared to the adult population, cancer in children is rare --- about 130 new cases per million children per year. So in pediatric oncology, we have to form these cooperatives like the Children's Oncology Group. We have to pool the resources and the number of patients from about 230 institutions around the country that belong to COG. That's the only way to get some meaningful statistical information to see how well any of our treatments are doing.”
Karen K. Fields, M.D., Moffitt’s medical director for the new Total Cancer Care effort, says that the depth of experience created with the cooperation of Moffitt’s 14 affiliates will be brought to bear to improve outcomes for children with cancer. “By sharing patient care and information, a greater number of patients with cancer are being helped today,” Fields says of the statewide team concept that offers patients throughout Florida access to the newest forms of cancer treatment and participation in clinical trials.